Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grehl

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cerebellum (London, England)|October 28, 2014
What does low-intensity rTMS do to the cerebellum?N Morellini, S Grehl, A Tang, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck regionG F Lehnerdt, A Bankfalvi, S Grehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2009
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinomaG F Lehnerdt, P Franz, A Bankfalvi, et al.
Science Advances|November 7, 2019
Neural circuit repair by low-intensity magnetic stimulation requires cellular magnetoreceptors and specific stimulation patternsT Dufor, S Grehl, A D Tang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cerebellum (London, England)|October 28, 2014
What does low-intensity rTMS do to the cerebellum?N Morellini, S Grehl, A Tang, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2009
No association of the NF-kappaB1 -94ins/delATTG promoter polymorphism with relapse-free and overall survival in patients with squamous cell carcinomas of the head and neck regionG F Lehnerdt, A Bankfalvi, S Grehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2009
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinomaG F Lehnerdt, P Franz, A Bankfalvi, et al.
Science Advances|November 7, 2019
Neural circuit repair by low-intensity magnetic stimulation requires cellular magnetoreceptors and specific stimulation patternsT Dufor, S Grehl, A D Tang, et al.
Pageof 1